Longduoduo Company Limited
Longduoduo Company Limited
Your view on LDDD
Overview
What the company does, where it operates, and who runs it.
About Longduoduo Company Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Hongxiao Zhou
- Headquarters
- G3-5-8016 Shui’an Town, Hohhot, CN
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Hongxiao Zhou
- Headquarters
- G3-5-8016 Shui’an Town, Hohhot, CN
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China.
The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents.
It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Longduoduo Company Limited, and the rating behind it. LDDD last traded at $0.51; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Longduoduo Company Limited. Starting points for Longduoduo Company Limited: EPS -$0.01, beta 1.50 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Longduoduo Company Limited. Longduoduo Company Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Longduoduo Company Limited. Trailing twelve-month EPS for Longduoduo Company Limited stands at -$0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Longduoduo Company Limited. Longduoduo Company Limited has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Longduoduo Company Limited valued side by side against its closest peers. Longduoduo Company Limited is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Longduoduo Company Limited, and how their positions are changing. At a $15.3M market value, institutional positions materially move Longduoduo Company Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Longduoduo Company Limited executives and directors. Shares of Longduoduo Company Limited have traded between $0.51 and $5.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Longduoduo Company Limited. Longduoduo Company Limited is a $15.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Longduoduo Company Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Longduoduo Company Limited. Coverage tracks Longduoduo Company Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.